AstraZeneca

Photo: The Economic Times

DCGI Allows Usage Of Covishield Vaccine For 9 Months From Manufacture

Drug Controller General of India on March 31 extended the usage time limit of Oxford-AstraZeneca's COVID-19 vaccine Covishield. The vaccine earlier permitted usage for six months after the date of manufacture, can now be used for nine months from its manufacturing date. Writing to the Serum Institute of India, the DCGI stated that all details about the stock should be submitted to DCGI's office and Central Drugs Authority.

Wed, 31 Mar 2021 - 09:45 PM / by Nikita Thakur

Tags: COVISHIELD, Serum Institute of India, Coronavirus Vaccines, DCGI

Courtesy: Times Now

Representational photo: Covid-19 vaccine.

Photo: Telegraph India

Jharkhand Woman Allegedly Forced To Take COVID Vaccine Jab, Dies

A 72-year-old woman, Devmani Dev, from Jharkhand's Orsa Path village died on March 23, just two days after being administered with the COVID-19 vaccine. Devmani's grandson Ranbir Yadav has claimed that local health workers pressurized his grandmother by saying that if she avoided the inoculation then she would not be given ration and pension. However, the Latehar District Administration has denied the allegations and said that the deceased… read-more

Fri, 26 Mar 2021 - 01:28 PM / by Harsh Vardhan

Tags: Jharkhand, COVISHIELD, Latehar, Covid-19 Vaccination

Courtesy: The Indian Express

Representational photo: Woman getting vaccinated.

Photo: DW

Centre Allows All 45+ For COVID Jab; Nixes Mandatory Health Certificate

The Centre, on March 23, announced to open COVID-19 vaccination for everyone above 45 years in its attempt to speed up the nationwide inoculation drive. Union Minister Prakash Javadekar clarified that people above 45-year-old will no longer require to produce co-morbidity certificates. The move came after the Centre widened the Covishield dosage gap from four to eight weeks on March 22. The government has requested several states to open… read-more

Tue, 23 Mar 2021 - 07:16 PM / by Harsh Vardhan

Tags: Central Government, Prakash Javadekar, COVISHIELD, Inoculation Drive

Courtesy: Hindustan Times

Representational photo: Covishield Vaccine.

Photo: The Tribune

Centre Orders Increasing Gap Of Vaccine Interval To 4-8 Weeks

The Centre, on March 22, directed all states and union territories to increase vaccine dose interval from existing 4-6 weeks to 4-8 weeks. Notably, the recommendation based on the vaccine administration's expert committee is only for the 'Covishield' vaccine and not for 'Covaxin'. The Centre's decision is inspired by scientific evidence that shows protection against coronavirus is enhanced if Covishield's second dose is administered between 6… read-more

Mon, 22 Mar 2021 - 05:32 PM / by Harsh Vardhan

Tags: Central Government, COVISHIELD, Covaxin, Coronavirus

Courtesy: Business Standard

Billboards Thanking PM Modi

Photo: OpIndia

Billboards Displayed In Canada To Thank PM Modi For COVID-19 Vaccine

Billboards thanking PM Narendra Modi for the COVID-19 vaccine have been put up in Greater Toronto, Canada. The billboards read, "Thank You India and PM Narendra Modi for providing COVID vaccines to Canada. Long Live Canada-India Friendship." Moreover, Canadian PM Justin Trudeau also expressed his gratitude saying that if the world conquers COVID-19 "it would be significantly because of India's tremendous pharmaceutical capacity." Earlier, on… read-more

Thu, 11 Mar 2021 - 12:35 PM / by Nikita Thakur

Tags: Canada, Toronto, PM Narendra Modi, COVISHIELD

Courtesy: Livemint

Representational Image

Photo: The Indian Express

Pune Court Rejects Cutis' Suit Against Serum Institute Over "Covishield" Name

A Pune court has rejected Cutis Biotech’s claim seeking the Serum Institute of India to drop the use of trademark ‘Covishield’ for its COVID-19 vaccine. Rejecting Cutis’ application, the court observed that the company had approached it with "suppressed… read-more

Sun, 31 Jan 2021 - 12:35 AM / by Sakshi Teresa Emmanuel

Tags: Serum Institute of India, Cutis Biotech, COVISHIELD, lawsuit, trademark, civil court, High Court, Pune, Maharashtra

Courtesy: NDTV

Frozen Covishield Vaccine Found In Assam

Photo: NDTV

1,000 Covishield Doses Found Frozen At Assam's Medical College

Assam's Silchar Medical College and Hospital witnessed a total of 1,000 doses of spoiled 'Covishield' vaccines due to extreme cold storage temperatures. While the ideal storage temperature for the vaccine is 2-8°C, the temperature of the storage facility at SMCH slumped to minus 5-6°C, freezing the vaccines. Instigating a probe into the matter, the state Health Minister Himanta Biswa Sarma said the lapses might have occurred probably due to… read-more

Wed, 20 Jan 2021 - 11:00 AM / by Sakshi Teresa Emmanuel

Tags: COVISHIELD, Vaccine Storage, Assam, Extreme Temperature Silchar Medical College and Hospital, Health Minister, Himanta Biswa Sarma, National Health Mission

Courtesy: The Times Of India

Covishield

Photo: Deccan Herald

India Gifts 1.5 Lakh Serum Institute's 'Covishield' Vaccines To Bhutan

Strengthening India-Bhutan relationships, the Centre on January 20 dispatched 1.5 lakh doses of Covishield vaccine to Bhutan. Interestingly, Bhutan became the first foreign country to receive the vaccines developed by the Serum Institute of India. Earlier, throughout the COVID-19 pandemic, India has supplied medicines, medicinal equipment and essential commodities to Bhutan. Besides, India also repatriated over 2,000 Bhutanese nationals… read-more

Wed, 20 Jan 2021 - 09:34 AM / by Nikita Thakur

Tags: India, Bhutan, COVISHIELD, COVID-Vaccine

Courtesy: Times Now

Covishield Vaccine

Photo: Live Mint

Maldives Becomes First Country To Receive India's Covishield Vaccine

After the government approved COVID Vaccine consignment, Maldives will become the first country to be aided by India's Covishield vaccine. Reportedly, the consignment, sufficient for the frontline workers and senior citizens of Maldives, will land at Velana International Airport, Malé in an Air-India flight on January 20. However, the Island is currently the largest COVID-19 assistance recipient in India's neighbourhood including medical… read-more

Tue, 19 Jan 2021 - 05:57 PM / by Sakshi Teresa Emmanuel

Tags: COVISHIELD, Covid -19, Coronavirus Vaccines, Maldives, Humanitarian Help

Serum Institute of India facility.

Photo: Scroll

4 More Vaccines Under Development, Says SII Executive Director

Executive Director of Serum Institute of India (SII), Suresh Jadhav, has informed that the company is currently working on four more covid-19 vaccines apart from Covishield. Suresh said, "Three others are in different stages of clinical studies while one is in the pre-clinical stage of the trial". Reportedly, SII has collaborated with US firms like Codagenix and Novavax inc aiming to produce 200 crore doses of vaccine.

Sun, 17 Jan 2021 - 02:15 PM / by Harsh Vardhan

Tags: SII, Suresh Jadhav, COVISHIELD, Coronavirus Vaccine

Courtesy: Business Insider